These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8161718)

  • 1. Dose dependent absorption and linear disposition of cyclosporin A in rat.
    Lindberg-Freijs A; Karlsson MO
    Biopharm Drug Dispos; 1994 Jan; 15(1):75-86. PubMed ID: 8161718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent dose-dependent oral absorption of cyclosporin A in rats.
    Ueda CT; Lemaire M; Gsell G; Misslin P; Nussbaumer K
    Biopharm Drug Dispos; 1984; 5(2):141-51. PubMed ID: 6743782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin pharmacokinetics after intravenous and oral administration in patients with Crohn's disease.
    Brynskov J; Freund L; Campanini MC; Kampmann JP
    Scand J Gastroenterol; 1992 Nov; 27(11):961-7. PubMed ID: 1455195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.
    Reymond JP; Steimer JL; Niederberger W
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):331-53. PubMed ID: 3193363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.
    Tanaka C; Kawai R; Rowland M
    Drug Metab Dispos; 2000 May; 28(5):582-9. PubMed ID: 10772639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
    Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
    Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of streptozotocin-induced diabetes on cyclosporin A disposition in rats.
    Ogata M; Iizuka Y; Murata R; Hikichi N
    Biol Pharm Bull; 1996 Dec; 19(12):1586-90. PubMed ID: 8996644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and absolute bioavailability of cyclosporin following intravenous and abomasal administration to sheep.
    Charles BG; Filippich LJ; Pass MA
    J Pharm Pharmacol; 1993 Sep; 45(9):821-4. PubMed ID: 7903372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
    Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
    Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in oral bioavailability of cyclosporin A by coadministration of probucol in rats.
    Sugimoto K; Sakamoto K; Fujimura A
    Life Sci; 1997; 60(3):173-9. PubMed ID: 9000641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine.
    Gomez DY; Wacher VJ; Tomlanovich SJ; Hebert MF; Benet LZ
    Clin Pharmacol Ther; 1995 Jul; 58(1):15-9. PubMed ID: 7628178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine.
    Wu CY; Benet LZ; Hebert MF; Gupta SK; Rowland M; Gomez DY; Wacher VJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):492-7. PubMed ID: 7586942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
    Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
    Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronopharmacokinetics of Cyclosporine A in the Wistar rat following oral administration.
    Malmary MF; Kabbaj K; Labat C; Batalla A; Houti I; Moussamih S; Oustrin J
    Eur J Drug Metab Pharmacokinet; 1992; 17(2):135-44. PubMed ID: 1425812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-insulin dependent diabetes on cyclosporin A disposition in Goto-Kakizaki (GK) rats.
    Ogata M; Uchimura T; Iizuka Y; Murata R; Suzuki S; Toyota T; Hikichi N
    Biol Pharm Bull; 1997 Sep; 20(9):1026-9. PubMed ID: 9331992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations.
    Sampath C; Haug K; Thanei S; Hamburger M; Derendorf H; Frye R; Butterweck V
    Planta Med; 2012 Apr; 78(6):575-81. PubMed ID: 22411722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.